HCP Inc (NYSE:HCP) shares traded -0.98% down during most recent session to reach at the closing price of $31.23. The stock exchanged hands 2.67 Million shares versus average trading capacity of 3.87 Million shares, yielding a market cap of $14.76 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $31.9 within the next 52-weeks. The mean target projections are based on 15 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have HCP Inc (NYSE:HCP) high price target of $35 and with a conservative view have low price target of $30.
Evercore ISI Group “Downgrades” HCP Inc (NYSE:HCP) in a research note issued to investors on 4/24/17 to Underperform with price target of $0.
Additionally on 4/11/17 Mizuho “Downgrades” HCP Inc (NYSE:HCP) to Neutral setting price target at $32 and on 4/03/17 Bank of America “Upgrades” the stock to Buy at $0. Furthermore on 3/27/17 Evercore ISI Group “Upgrades” the stock to In-Line at $0.
On the other hand the company has Relative Strength Index (RSI 14) of 49.44 along with Average True Range (ATR 14) of 0.54, Consequently HCP Inc (NYSE:HCP)’s weekly and monthly volatility is 1.21%, 1.82% respectively. The company’s beta value is at 0.4.
In terms of Buy, Sell or Hold recommendations, HCP Inc (NYSE:HCP) has analysts’ mean recommendation of 3. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts HCP Inc (NYSE:HCP)’s minimum EPS for the current quarter is at $0.14 and can go high up to $0.31. The consensus mean EPS for the current quarter is at $0.19 derived from a total of 6 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.64 earnings per share for the same quarter during last year.
Previously HCP Inc (NYSE:HCP) reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.66. The company posted an earnings surprise of 212.9%.
While considering growth estimates of the company, it has next quarter growth estimates of -40.6% whereas during current quarter it has -70.3% estimations over growth, comparing to the estimations of 0.7% during current year and -39.7% for next year. Past 5 years growth of HCP Inc (NYSE:HCP) observed at -8.84%, looking forward for the next 5 years it has a strong prediction of 2.5% over growth.
HCP Inc (NYSE:HCP)’s revenue estimates for the current quarter are $468.79 Million according to 5 number of analysts, for the current quarter the company has high revenue estimates of $527.3 Million in contradiction of low revenue estimates of $441.82 Million. For the current year the company’s revenue estimates are $1.96 Billion compared to low analyst estimates of $1.81 Billion and high estimates of $2.12 Billion according to 9 number of analysts.
Currently HCP Inc (NYSE:HCP)’s shares owned by insiders are 0.2%, whereas shares owned by institutional owners are 91.6%. However the six-month change in the insider ownership was recorded -2.73%, as well as three-month change in the institutional ownership was recorded -2.78%.
HCP Inc (NYSE:HCP) 52-week high price stands at $36.81 and low price stands at $27.61, its price distance from 52-week high is -15.15% while its distance from 52-week low price is 13.11%. The stock hit its 52-week high on 09/07/16, and 52-week low on 11/10/16.
HCP Inc (NYSE:HCP)’s trailing twelve month revenues are $2.1 Billion, whereas its price to sales ratio for the same period is 7.03. Its book value per share for the most recent quarter is $12.47 while its price to book ratio for the same period is 2.5, as for as the company’s cash per share for the most recent quarter is $1.61, however its price to cash per share ratio for the same period is 19.34. The stock has 5 year expected PEG ratio of 7.62 whereas its trailing twelve month P/E ratio is 19.05.